|
CDC Coronavirus Treatment Acceleration Program
IDSA Updated Guidelines on Serologic Testing for the Diagnosis of COVID-19
IDSA COVID-19 Diagnostic Guidelines
IDSA Infection Prevention Guidelines
IDSA Treatment and Management Guidelines for Patients With COVID-19
Coronavirus Disease Outbreak in Call Center, South Korea
CDC Interim Guidance for Essential Workers Who May Have COVID-19 Exposure
CDC COVID-19 Information for Healthcare Professionals
Strategies for Optimizing the Supply of PPE
Interim Infection Prevention and Control Recommendations for Healthcare Settings
CDPH Remdesivir Distribution Guidance
Updated Interim Guidance on Prioritization for COVID-19 Laboratory Testing
AFL: Interim Guidance for Transfer of Residents with Suspected or Confirmed (COVID-19)
Outpatient Healthcare Facility Infection Control Recommendations for Suspect COVID-19 Patients
Suspension of Regulatory Enforcement of Hospital Requirements
Preparing for Coronavirus Disease 2019 (COVID-19) in California Skilled Nursing Facilities
CDPH Guidance fro Prioritization of Patients for Laboratory Testing for COVID-19
FDA
FDA Policy for Diagnostic Tests for Coronavirus Disease-2019 Issued 4/16/2020
FDA Issues EUA for COVID-19 Antibody Testing (IgM and IgG) to Cellex, Inc.
Emergency Use Authorization for Chloroquine From the Strategic StockpileQuest: COVID-19: Information for Healthcare Professionals
LabCorp: Information about Coronavirus Disease 2019 (COVID-19)
Abbott: Point of Care Rapid COVID-19 Testing - ID Now
Quick links |
© Infectious Disease Association of California